Global Drug Delivery Technology Market Report 2015 - Forecasts to 2020 for the $1.5 Billion Industry

Dublin, Nov. 30, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/js7c4m/drug_delivery) has announced the addition of the "Drug Delivery Technology Market 2015 - Forecast to 2020" report to their offering.

The drug delivery technology market is expected to reach USD 1,504.7 billion by 2020 from USD 1,048.1 billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020

The market is categorized on the basis of route of administration, end user, and region. The route of administration market is further segmented into oral, pulmonary, ocular, nasal, topical, injectable, implantable and transmucosal drug delivery technology. The topical drug delivery technology market segment is expected to witness the highest CAGR in the forecast period.

Factors such as rising incidences of chronic diseases, growth of the biologics market, and innovation and technological advancements, are driving the growth of the drug delivery technology market. In addition, emphasis on innovation for improving the delivery of drugs is also contributing to the growth of the market. For instance, in February 2015, Sanofi and Mankind Corporation (U.S.) collaborated to launch Afrezza (insulin human) Inhalation Powder, inhalable insulin. This launch enabled the company to strengthen its product portfolio in nasal drug delivery. Such innovations are fueling the growth of the market.

Asia is expected to be the fastest-growing region in the drug delivery technology market. High growth in this market can be attributed to the increased population, rising prevalence of chronic diseases in the emerging markets, and existence of unmet medical needs.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the drug delivery technology market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future.

Key players in the drug delivery technology market include Pfizer, Inc. (U.S.), Roche (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Novartis AG (Switzerland), and Bayer AG (Germany).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Drug Delivery Technology Market, By Route Of Administration

7 Drug Delivery Technology Market, By End User

8 Drug Delivery Technology Market, By Region

9 Competitive Landscape

10 Company Profiles

- 3M Company
- Antares Pharma, Inc.
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Glaxosmithkline Plc
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Sanofi

For more information visit http://www.researchandmarkets.com/research/js7c4m/drug_delivery

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Medical Devices, Transdermal and Transmucosal Drug Delivery, Infusions and Injectables , Inhalers and Nebulisers, Optical